Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 7, 2014; 20(37): 13343-13368
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13343
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13343
Virus | Viral genome | Insertion capacity | Host range of infection | State of integration into host genome | Efficiency of gene transfection and expression | Immunogenicity | Titers of preparation in vitro(PFU/mL) | Bio-safety |
AdV | Double-stranded DNA | 38 kb | Broad spectrum (both dividing and non-dividing cells) | No integration | High | High | 1011-1012 | Safe |
AAV | Single-stranded DNA | 4.9 kb | Broad spectrum | Site-specific integration on chromosome 19q13.3 | High | Low | 1012, dependent on helper virus | Safe |
RV | Single-stranded RNA | 8 kb | Dividing cells only | Integrate randomly | Low | Low | 106-107 | Risk of insertional mutagenesis |
Lentivirus | Single-stranded RNA | 8 kb | Broad spectrum | Integrate randomly | High | Low | 109-1010 | Risk of viral infection and insertional mutagenesis |
Pox virus | Souble-stranded DNA | 25 kb | Broad spectrum | No integration | High | High, function as immunologic adjuvant | 106-107 | Safe |
HSV | Double-stranded DNA | 15-30 kb | Nerve cells and epithelial cells, especially neuro- tropic speciality | No integration | High | Moderate | 1011-1012 | Risk of viral infection |
- Citation: Liu SX, Xia ZS, Zhong YQ. Gene therapy in pancreatic cancer. World J Gastroenterol 2014; 20(37): 13343-13368
- URL: https://www.wjgnet.com/1007-9327/full/v20/i37/13343.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i37.13343